FDA considering plan to promote reduced-risk products over cigarettes: report
© Getty Images

The Food and Drug Administration (FDA) is considering a new plan to promote reduced-risk tobacco products over cigarettes, which administrators hope will lower rates of smoking in future generations. 

In a two-pronged plan, the FDA aims to significantly cut the amount of nicotine in cigarettes and review a number of cigarette alternatives that are considered less dangerous, according to The Associated Press


The agency gained power to regulate the addictive chemical in 2009 with the passage of the Family Smoking Prevention and Tobacco Control Act, which has also allowed the agency to oversee the rollout of smoking devices such as e-cigarettes. 

The FDA will hold a public meeting next week on whether the agency should approve the sale of a new tobacco product called iQOS that heats tobacco instead of vaporizing liquid containing nicotine like other e-cigarettes. The new product could go on sale in February if approved. 

Critics of the new FDA initiative say that the agency should focus on prevention and helping people stop smoking, and that new products could actually start more people smoking because they could be perceived as low-risk alternatives. 

The new plan comes as the Trump administration is considering a move to reorganize the Bureau of Alcohol, Tobacco, Firearms and Explosives that would remove its mandate to deal with alcohol- and nicotine-related smuggling and focus more on violent crime investigation.